These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36110318)

  • 21. Surface Modified Ti
    Liu G; Zou J; Tang Q; Yang X; Zhang Y; Zhang Q; Huang W; Chen P; Shao J; Dong X
    ACS Appl Mater Interfaces; 2017 Nov; 9(46):40077-40086. PubMed ID: 29099168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CuInS/ZnS quantum dots modified intraocular lens for photothermal therapy of posterior capsule opacification.
    Mao Y; Yu S; Kang Y; Zhang D; Wu S; Zhang J; Xiong Y; Li M; Zhang J; Wang J; Wang K; Wan X
    Exp Eye Res; 2021 Jan; 202():108282. PubMed ID: 33049272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-Eluting Hydrophilic Coating Modification of Intraocular Lens via Facile Dopamine Self-Polymerization for Posterior Capsular Opacification Prevention.
    Liu S; Zhao X; Tang J; Han Y; Lin Q
    ACS Biomater Sci Eng; 2021 Mar; 7(3):1065-1073. PubMed ID: 33492923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cascade reaction triggering and photothermal AuNPs@MIL MOFs doped intraocular lens for enhanced posterior capsular opacification prevention.
    Hong Y; Fang Q; Bai T; Zhao P; Han Y; Lin Q
    J Nanobiotechnology; 2023 Apr; 21(1):134. PubMed ID: 37095517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmented cellular uptake and homologous targeting of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety improvement.
    Zhu S; Huang H; Liu D; Wen S; Shen L; Lin Q
    Bioact Mater; 2022 Sep; 15():469-481. PubMed ID: 35386342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-loaded and Blue-ray Filtered Hydrogel as a Potential Intraocular Lens for Cataract Treatment.
    Xiang Y; Zou M; Zhang Y; Jin R; Nie Y
    Pharm Nanotechnol; 2020; 8(4):302-312. PubMed ID: 32167435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid and Economical Drug-Eluting IOL Preparation via Thermoresponsive Agarose Coating for Effective Posterior Capsular Opacification Prevention.
    Chen S; Qin C; Fang Q; Duo L; Wang M; Deng Z; Chen H; Lin Q
    Front Bioeng Biotechnol; 2022; 10():930540. PubMed ID: 35992334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantation of a single-piece, hydrophilic, acrylic, minus-power foldable posterior chamber intraocular lens in a rabbit model: clinicopathologic study of posterior capsule opacification.
    Vargas LG; Izak AM; Apple DJ; Werner L; Pandey SK; Trivedi RH
    J Cataract Refract Surg; 2003 Aug; 29(8):1613-20. PubMed ID: 12954315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on fixation of rigid and foldable posterior chamber intraocular lenses. Part II: Choosing the correct haptic fixation and intraocular lens design to help eradicate posterior capsule opacification.
    Ram J; Apple DJ; Peng Q; Visessook N; Auffarth GU; Schoderbek RJ; Ready EL
    Ophthalmology; 1999 May; 106(5):891-900. PubMed ID: 10328386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-viral gene coating modified IOL delivering PDGFR-α shRNA interferes with the fibrogenic process to prevent posterior capsular opacification.
    Wang J; Hu Y; Han Y; Fang Q; Chen Z; Wang Y; Zhao P; Wang H; Lin Q
    Regen Biomater; 2023; 10():rbad020. PubMed ID: 36950659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraocular lenses as drug delivery devices.
    Topete A; Saramago B; Serro AP
    Int J Pharm; 2021 Jun; 602():120613. PubMed ID: 33865952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Translation of Long-Acting Drug Delivery Systems for Posterior Capsule Opacification Prophylaxis.
    Li X; Liang C; Guo Y; Su J; Chen X; Macgregor RB; Zhang RX; Yan H
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photothermal Ring Integrated Intraocular Lens for High-Efficient Eye Disease Treatment.
    Lin YX; Hu XF; Zhao Y; Gao YJ; Yang C; Qiao SL; Wang Y; Yang PP; Yan J; Sui XC; Qiao ZY; Li LL; Xie JB; Zhu SQ; Wu XC; Li Y; Wang L; Wang H
    Adv Mater; 2017 Sep; 29(34):. PubMed ID: 28714205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of posterior capsulotomy with vitrectomy and intraocular lens design and material in reducing posterior capsule opacification after pediatric cataract surgery.
    Ram J; Brar GS; Kaushik S; Gupta A; Gupta A
    J Cataract Refract Surg; 2003 Aug; 29(8):1579-84. PubMed ID: 12954310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The intraocular lens as a drug delivery device for an epidermal growth factor-Receptor inhibitor for prophylaxis of posterior capsule opacification.
    Wertheimer C; Kueres A; Siedlecki J; Braun C; Kassumeh S; Wolf A; Mayer W; Priglinger C; Priglinger S; Eibl-Lindner K
    Acta Ophthalmol; 2018 Nov; 96(7):e874-e882. PubMed ID: 29855160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posterior Capsule Opacification and Nd-YAG rates evaluation in a large series of pseudophakic cases.
    Iliescu IM; Constantin MA; Cozma C; Moraru OM; Moraru CM
    Rom J Ophthalmol; 2017; 61(4):267-274. PubMed ID: 29516046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification.
    Zhang X; Lai K; Li S; Wang J; Li J; Wang W; Ni S; Lu B; Grzybowski A; Ji J; Han H; Yao K
    Bioact Mater; 2022 Mar; 9():343-357. PubMed ID: 34820575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(lactic-co-glycolic) Acid as a Slow-Release Drug-Carrying Matrix for Methotrexate Coated onto Intraocular Lenses to Conquer Posterior Capsule Opacification.
    Kassumeh SA; Wertheimer CM; von Studnitz A; Hillenmayer A; Priglinger C; Wolf A; Mayer WJ; Teupser D; Holdt LM; Priglinger SG; Eibl-Lindner KH
    Curr Eye Res; 2018 Jun; 43(6):702-708. PubMed ID: 29451997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro system to investigate IOL: Lens capsule interaction.
    Jaitli A; Roy J; Mcmahan S; Liao J; Tang L
    Exp Eye Res; 2021 Feb; 203():108430. PubMed ID: 33422509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraocular lens decentration and posterior capsule opacification: anatomo-pathologic findings after implantation of AMOSI40 IOLS.
    Tognetto D; Sanguinetti G; Cernobori R; Basile A; Ravalico G; Bussani R; Silvestri F
    Eur J Ophthalmol; 2006; 16(1):46-51. PubMed ID: 16496245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.